Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Frontotemporal Lobar Degeneration: later-stage trial registry
3 of 7 indexed Frontotemporal Lobar Degeneration trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 3 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Frontotemporal Lobar Degeneration: 7 US clinical trials tracked, 3 recruiting.
Frontotemporal Lobar Degeneration is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is The Bluefield Project to Cure Frontotemporal Dementia, running 1 of these trials.
Enrollment posture brief
Registry condition frontotemporal-lobar-degeneration
OPEN 3 | RECR 43% | LATE 1 | EARLY 0 | RANK #2497 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adrenoleukodystrophy (43% recruiting · 7 trials)
Frontotemporal Lobar Degeneration lists 3 open slots (43% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Frontotemporal Lobar Degeneration on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Frontotemporal Lobar Degeneration is recruiting below its size-band peers.
3 of 7 indexed trials (42.9%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Frontotemporal Lobar Degeneration trials is spread across many organizations.
The Bluefield Project to Cure Frontotemporal Dementia accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.
-
Typical Frontotemporal Lobar Degeneration enrolment sits around 72 participants.
Median target enrolment is 72 among the 7 trials that report a genuine target (sentinel values excluded). 4 of those (57.1%) plan for fewer than 100 participants.
-
Frontotemporal Lobar Degeneration splits between interventional and observational designs.
3 interventional and 4 observational studies make up this index (42.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their Caregivers
University of Washington
NCT05596760
PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620
University of Pennsylvania
NCT05456503
Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia
University of Texas at Austin
NCT05741853
Neurofilament Surveillance Project (NSP)
The Bluefield Project to Cure Frontotemporal Dementia
NCT04516499
A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes
Massachusetts General Hospital
NCT05956834
PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in Frontotemporal Dementia
National Institute of Mental Health (NIMH)
NCT00613119
Treatment Study of Frontotemporal Dementia
National Institute of Neurological Disorders and Stroke (NINDS)
NCT00088751
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Frontotemporal Lobar Degeneration records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Frontotemporal Lobar Degeneration trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Frontotemporal Lobar Degeneration page
7 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Frontotemporal Lobar Degeneration trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- The Bluefield Project to Cure Frontotemporal Dementia sponsors the most Frontotemporal Lobar Degeneration trials on record, review their full trial history before evaluating a specific study. See The Bluefield Project to Cure Frontotemporal Dementia's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Frontotemporal Lobar Degeneration condition card totals 7 registered trials; most-linked intervention LEGSys; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.